Which class of medication is primarily used to manage palpitations caused by supraventricular tachycardia?
সঠিক উত্তর: Option B
- The primary goal in managing palpitations caused by supraventricular tachycardia (SVT) is to slow down the ventricular rate and restore normal sinus rhythm.
- Among the medication classes listed, beta-blockers are commonly preferred because of their safety profile and effectiveness in controlling the heart rate.
- Beta-blockers work by blocking the β-adrenergic receptors, leading to a reduction in sympathetic stimulation of the heart.
- This results in slowing of the atrioventricular (AV) node conduction, which is crucial in terminating or controlling SVT episodes.
- They are effective in both acute management and prevention of recurrent SVT.
Other options:
- Calcium channel blockers (such as verapamil and diltiazem) also slow AV node conduction and can be used in SVT; however, beta-blockers are generally preferred due to a better side-effect profile in many patients.- Class IA antiarrhythmics (e.g., quinidine) are not first-line agents for SVT. They are more commonly used for ventricular arrhythmias and have more proarrhythmic potential.
- Potassium channel blockers (Class III agents like amiodarone) are typically reserved for more complex arrhythmias or refractory cases due to their extensive side effect profile.
In summary: Beta-blockers are the first-line pharmacologic agents for managing palpitations caused by SVT because of their effectiveness in slowing AV node conduction and improving symptoms with a favorable safety profile.
Reference: Braunwald’s Heart Disease, 11th Edition, Volume 1, Chapter 35 – Supraventricular Arrhythmias, pp. 850-860.